Thomas John 4

What Happened
Thomas John, a director of GENELUX Corp (GNLX), received two equity grants on June 16, 2026: 28,409 restricted stock units (RSUs) and 31,566 derivative awards (options/other contingent awards). Both grants were reported as acquired at $0.00, so there was no cash paid at grant; the total notional number of shares involved is 59,975.

Key Details

• Transaction date: 2026-06-16; Form 4 filed: 2026-06-18 (appears timely — within the usual 2-business-day window).
• Grant prices: $0.00 for both awards; total reported cash value at grant = $0.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote F1: The 28,409 awards are RSUs — each RSU converts to one share upon vesting. Vesting occurs on the earlier of (a) one year from grant or (b) the issuer’s next annual meeting.
• Footnote F2: The 31,566 award is a derivative (option-like) award; vesting follows the same earlier-of schedule in F1.
• Transaction type code: A = Award/Grant.

Context
RSUs and derivative awards are compensatory grants to align directors’ interests with shareholders; they are not open-market purchases or sales and do not indicate an immediate cash investment or disposition. The RSUs convert to common stock when they vest; the derivative award will similarly vest into shares according to the stated schedule. These awards become meaningful only if and when they vest (and, for options, if exercised).